On Wednesday, March 12, 2025, the conference "Scientific research projects tailored to business - experiences and opportunities in the pharmaceutical industry" was held at the Serbian Chamber of Commerce. During the meeting, Dr. Ana Đorđević presented the potential of IBISS for cooperation with the pharmaceutical industry, as well as the ongoing collaborative UTRL project "LiverDophilus - Probiotic bacteria for the treatment of liver steatosis", which is funded through SAIGE and realized through the cooperation between IBISS, IMGGI and the pharmaceutical company Phytonet.
On March 11-12, 2025, the Institute for Biological Research “Siniša Stanković” hosted an intensive hands-on training session focused on mass spectrometry data processing in lipidomics. This training was a sort of continuation and deepening of the Training in Analytical Methods for Mass Spectrometry-based Lipidomics held in October of the previous year, aimed at engaging participants more actively with real research datasets.
The first training on EU research funding and project management, organized as part of the STRIMHealth project, has been successfully completed. Held at IBISS on March 10th, Belgrade, the training covered key topics on funding opportunities and the grant preparation process.
As part of the STRIMHealth project activities aimed at enhancing project proposal writing and the implementation of EU-funded projects, we are pleased to announce the Workshop on Research Data Management (RDM). The workshop will be held online on March 17–18, 2025.
It is a pleasure for the STRIMHealth team from the University of Belgrade – Institute for Biological Research “Siniša Stanković” (IBISS) to announce the 2nd Training on Targeted and Non-targeted MS-data Analysis in Lipidomics that will be hosted at IBISS (Belgrade, Serbia) from March 11 – 12, 2025.
As part of the STRIMHealth project activities to improve the research management skills of IBISS researchers and staff, we are pleased to announce the Training on EU-based research funding and project management, which will take place on March 10, 2025, at the Library of the Institute for Biological Research “Siniša Stanković” (Belgrade, Serbia).
On 04th February 2025, Dr. Milica Pešić, a representative of the IBISS KTT team in the BIO4 delegation, visited Pfizer's Center for Digital Innovation in Thessaloniki, where she learned how the centre works. During the visit, she gave a short presentation. She presented IBISS as an institution with broad biodiversity, biotechnology, and biomedicine expertise that is open to collaboration and has great innovation potential.
Colleagues from the Department of Biochemistry have been awarded the Hop-on facility project entitled "Widening the investigation of endocrine-disrupting chemicals as contributors to progression of metabolic dysfunction-associated steatotic liver disease" (widenEDC-MASLD) under the HORIZON-WIDERA-2023-ACCESS-06 call.
The Goran Ljubijankić Foundation has presented awards for the best doctoral dissertations and master's theses in the field of molecular biology defended in 2024.
The work of Ana Stepanović and colleagues was selected in the competition of the "Akademik Radoslav K. Anđus" Foundation for the best scientific publication by a young scientist in the field of physiology/biophysics for 2023/2024: Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma, Biomedicine & Pharmacotherapy 174, 2024, 116496.
Phone: +381 11 20 78 300
Fax: +381 11 27 61 433
Email: ibiss@ibiss.bg.ac.rs
Bulevar despota Stefana 142
11108 Belgrade
Serbia
IBISS uses analytical cookies to analyze the use of the site in order to improve the user experience, by clicking "Accept" you consent to the use of cookies.